Introducing the Life Sciences Verification Program
Anthropic announced the Life Sciences Verification Program (LSVP), which gives life science professionals access to its Mythos, Opus, and Sonnet models with a refined set of safeguards that are more permissive for biology-related work. The company says it has already onboarded dozens of organizations through an early-access program and is now opening applications to the broader life science community. The program is launching in beta initially for teams and institutions, with plans to expand access to individual Pro and Max plans over time. It is designed to enable tasks currently blocked in generally available Fable models, such as drug discovery, research biology, clinical development, and manufacturing, and is aimed at teams ranging from academic labs to startups and pharma companies.
To qualify, each applicant goes through a verification process that includes a review of research credentials, security standards, and ethical research oversight. Once verified, teams may apply for two types of LSVP grants, Standard Use or High-risk Use, depending on their access needs. These grants can be used through all Anthropic product surfaces, including Claude Science, Claude.ai, Claude Code, and the API.
Standard Use grants are intended for most life science work, including the majority of biology research and development workflows. They can be extended to entire teams for diverse daily workloads and are renewed once a year. They provide access to Mythos, Opus, and Sonnet models with refined classifiers that are more permissive for science tasks than generally available models. Standard Use grants apply to Mythos 5.1, Opus 5, and Sonnet 5 today, and to future models as they launch. They are designed to cover activities across basic science, R&D, supply chain and manufacturing, clinical development, quality assurance, regulatory affairs, investing and diligence, and more.
High-risk Use is an add-on grant for teams working in areas blocked under Standard Use. It removes all safeguards that block life sciences requests. Unlike Standard Use, it applies to a single research project rather than a full team and must be renewed every six months. Typically, a single researcher with dual-use work would have one Standard Use grant for diverse daily activities plus one or more High-risk Use grants for specific projects, such as characterizing how one specific family of viral vectors is recognized by human immune pathways. High-risk grants for Claude Opus 5 and Claude Sonnet 5 are available today. The excerpt also notes Anthropic is working with the US government, though that sentence is truncated.